Congressional Stock Trades & Disclosures
Chris Jacobs is a U.S. Representative, a Republican representing NY. As of January 2023, Bullish Whales has tracked 260 disclosed stock trades across 142 companies, representing $3.2M in disclosed transaction value, each filed publicly under the STOCK Act.
About Jacobs's congressional trading
Jacobs's disclosed activity shows a sell-leaning pattern, with 115 purchases and 141 sales (a buy-to-sell ratio of 0.82). Jacobs has traded BAC, PFE, and HD most frequently among disclosed positions.
On the Bullish Whales Score, which ranks members of Congress by how worth-following their disclosed buys have been relative to peers, Jacobs rates 43 out of 100, a Mixed reading. The score weights a member's realized track record (80%) and conviction in repeat positions (20%); it is a descriptive research signal drawn from public filings, not investment advice.
Jacobs's most recent disclosed trade was a sale of Coterra Energy Inc (CTRA) from December 2022. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 CTRACoterra Energy Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 XOMExxon Mobil Corp | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 PCVXVaxcyte Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 TSLATesla Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 ATHAAthira Pharma Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 COGTCogent Biosciences Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 BACBank of America Corp | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 SWTXSWTX | Buy | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 PFEPfizer Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
 KURAKura Oncology Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | N/A | — |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Chris Jacobs congressional trading FAQ
Can Chris Jacobs legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles Chris Jacobs's disclosures so the public can review them.
Where does Bullish Whales get Chris Jacobs's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Chris Jacobs's stock trades?
Bullish Whales tracks every stock trade Chris Jacobs discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Chris Jacobs disclosed?
Bullish Whales has tracked 260 disclosed trades by Chris Jacobs across 142 companies.
Which stocks does Chris Jacobs trade most?
Chris Jacobs's most frequently disclosed positions include BAC, PFE, HD, JNJ, and SAVA. The full list of companies and individual filings is shown on this page.
What was Chris Jacobs's most recent stock trade?
Chris Jacobs most recently sold Coterra Energy Inc (CTRA) in December 2022, according to public STOCK Act filings tracked by Bullish Whales.
What is Chris Jacobs's Bullish Whales Score?
Chris Jacobs has a Bullish Whales Score of 43 out of 100 (Mixed). The score ranks members by how worth-following their disclosed buys have been, weighting realized track record (80%) and conviction (20%). It is a descriptive research signal, not investment advice.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.